Walgreen Boots Alliance (WBA) Tops Q2 EPS by 23c
Walgreen Boots Alliance (Nasdaq: WBA) reported Q2 EPS of $1.18, $0.23 better than the analyst estimate of $0.95. Revenue for the quarter came in at $26.6 billion versus the consensus estimate of $27.27 billion.
The Retail Pharmacy USA division, whose principal retail pharmacy brands are Walgreens and Duane Reade, had second quarter sales of $21.0 billion, an increase of 7.4 percent over the year-ago quarter. Total sales in comparable stores (those open at least a year) increased 6.9 percent compared with the same quarter a year ago. Retail comparable store sales increased 2.5 percent in the second quarter with improved retail product margins compared with last year’s second quarter.
Walgreen Boots Alliance sees FY2015 EPS of $3.45 - $3.65, versus the consensus of $3.61.
For earnings history and earnings-related data on Walgreen Boots Alliance (WBA) click here.